Neurotech Pharmaceuticals, Inc.
Laurie Ferguson is an experienced communications professional with a diverse background in the pharmaceutical, medical devices, and engineering sectors. Currently serving as Chief Communications Officer at Neurotech Pharmaceuticals, Inc., Ferguson has previously held significant roles such as Head of Ophthalmic Devices Global Communications at Carl Zeiss Meditec AG and Head of Global Corporate Communications at LivaNova. Additionally, Ferguson has worked as Manager of Marketing and Communications at Gulf Interstate Engineering and as Global Manager of Strategic Marketing & Communication at Baker Hughes.
This person is not in any teams
This person is not in any offices
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.